HEADER TRANSFERASE 27-NOV-22 8HKN TITLE MUTATED HUMAN ADP-RIBOSYLTRANSFERASE 2 (PARP2) CATALYTIC DOMAIN BOUND TITLE 2 TO APPROVED DRUG FLUZOPARIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 2; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: PARP-2,HPARP-2,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE COMPND 5 2,ARTD2,DNA ADP-RIBOSYLTRANSFERASE PARP2,NAD(+) ADP- COMPND 6 RIBOSYLTRANSFERASE 2,ADPRT-2,POLY[ADP-RIBOSE] SYNTHASE 2,PADPRT-2, COMPND 7 PROTEIN POLY-ADP-RIBOSYLTRANSFERASE PARP2; COMPND 8 EC: 2.4.2.30,2.4.2.-; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP2, ADPRT2, ADPRTL2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DNA ADP-RIBOSYLTRANSFERASE 2, PARP2, FLUZOPARIB, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR X.Y.WANG,J.ZHOU,B.L.XU REVDAT 1 01-MAY-24 8HKN 0 JRNL AUTH X.Y.WANG,J.ZHOU,B.L.XU JRNL TITL MUTATED HUMAN ADP-RIBOSYLTRANSFERASE 2 (PARP2) CATALYTIC JRNL TITL 2 DOMAIN BOUND TO APPROVED DRUG FLUZOPARIB JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.400 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 22769 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.840 REMARK 3 FREE R VALUE TEST SET COUNT : 1102 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.9800 - 5.0000 0.98 2741 125 0.1644 0.1978 REMARK 3 2 5.0000 - 3.9700 0.99 2733 125 0.1553 0.2246 REMARK 3 3 3.9700 - 3.4700 0.99 2694 121 0.1760 0.2464 REMARK 3 4 3.4700 - 3.1500 1.00 2685 154 0.1997 0.2666 REMARK 3 5 3.1500 - 2.9200 1.00 2675 152 0.2115 0.3103 REMARK 3 6 2.9200 - 2.7500 1.00 2704 153 0.2067 0.3430 REMARK 3 7 2.7500 - 2.6100 1.00 2747 134 0.2124 0.3468 REMARK 3 8 2.6100 - 2.5000 1.00 2688 138 0.2179 0.3360 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.401 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.420 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.22 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 5808 REMARK 3 ANGLE : 1.588 7848 REMARK 3 CHIRALITY : 0.077 844 REMARK 3 PLANARITY : 0.020 1010 REMARK 3 DIHEDRAL : 18.335 2202 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8HKN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 06-DEC-22. REMARK 100 THE DEPOSITION ID IS D_1300033794. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22769 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 39.980 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.3900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: ALPHAFOLD MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG-3350, 0.1 M TRIS-HCL PH 8.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.79200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HIS B 374 O HOH B 701 2.06 REMARK 500 O TYR B 362 O HOH B 702 2.10 REMARK 500 OD1 ASN A 481 O HOH A 701 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU B 350 -77.19 26.03 REMARK 500 ARG B 351 39.67 83.81 REMARK 500 SER B 376 146.24 -27.86 REMARK 500 HIS B 394 62.34 -117.90 REMARK 500 ARG B 417 77.05 -66.25 REMARK 500 ASN B 422 47.71 72.95 REMARK 500 LYS B 480 73.11 -118.32 REMARK 500 ASN B 502 92.93 -167.13 REMARK 500 PRO B 503 -16.61 -49.65 REMARK 500 PRO B 523 154.93 -46.09 REMARK 500 SER B 524 -72.01 -71.51 REMARK 500 SER B 525 -48.84 145.14 REMARK 500 ASP B 550 69.32 -111.76 REMARK 500 ARG B 570 -52.82 -128.75 REMARK 500 ARG A 322 -46.73 -142.04 REMARK 500 GLN A 352 -157.59 84.74 REMARK 500 HIS A 394 63.83 -107.61 REMARK 500 ASN A 502 94.88 -160.26 REMARK 500 LEU A 547 -42.17 -147.65 REMARK 500 ASP A 550 11.58 56.71 REMARK 500 TYR A 552 -44.50 -25.96 REMARK 500 THR A 553 123.03 74.23 REMARK 500 LEU A 554 119.46 90.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG B 308 0.14 SIDE CHAIN REMARK 500 ARG B 431 0.09 SIDE CHAIN REMARK 500 ARG B 478 0.26 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 8HKN B 230 581 UNP Q9UGN5 PARP2_HUMAN 230 581 DBREF 8HKN A 230 581 UNP Q9UGN5 PARP2_HUMAN 230 581 SEQADV 8HKN GLY B 229 UNP Q9UGN5 EXPRESSION TAG SEQADV 8HKN SER B 349 UNP Q9UGN5 THR 349 ENGINEERED MUTATION SEQADV 8HKN ARG B 351 UNP Q9UGN5 LEU 351 ENGINEERED MUTATION SEQADV 8HKN GLY B 353 UNP Q9UGN5 SER 353 ENGINEERED MUTATION SEQADV 8HKN LEU B 354 UNP Q9UGN5 PRO 354 ENGINEERED MUTATION SEQADV 8HKN GLY A 229 UNP Q9UGN5 EXPRESSION TAG SEQADV 8HKN SER A 349 UNP Q9UGN5 THR 349 ENGINEERED MUTATION SEQADV 8HKN ARG A 351 UNP Q9UGN5 LEU 351 ENGINEERED MUTATION SEQADV 8HKN GLY A 353 UNP Q9UGN5 SER 353 ENGINEERED MUTATION SEQADV 8HKN LEU A 354 UNP Q9UGN5 PRO 354 ENGINEERED MUTATION SEQRES 1 B 353 GLY PRO GLU SER GLN LEU ASP LEU ARG VAL GLN GLU LEU SEQRES 2 B 353 ILE LYS LEU ILE CYS ASN VAL GLN ALA MET GLU GLU MET SEQRES 3 B 353 MET MET GLU MET LYS TYR ASN THR LYS LYS ALA PRO LEU SEQRES 4 B 353 GLY LYS LEU THR VAL ALA GLN ILE LYS ALA GLY TYR GLN SEQRES 5 B 353 SER LEU LYS LYS ILE GLU ASP CYS ILE ARG ALA GLY GLN SEQRES 6 B 353 HIS GLY ARG ALA LEU MET GLU ALA CYS ASN GLU PHE TYR SEQRES 7 B 353 THR ARG ILE PRO HIS ASP PHE GLY LEU ARG THR PRO PRO SEQRES 8 B 353 LEU ILE ARG THR GLN LYS GLU LEU SER GLU LYS ILE GLN SEQRES 9 B 353 LEU LEU GLU ALA LEU GLY ASP ILE GLU ILE ALA ILE LYS SEQRES 10 B 353 LEU VAL LYS SER GLU ARG GLN GLY LEU GLU HIS PRO LEU SEQRES 11 B 353 ASP GLN HIS TYR ARG ASN LEU HIS CYS ALA LEU ARG PRO SEQRES 12 B 353 LEU ASP HIS GLU SER TYR GLU PHE LYS VAL ILE SER GLN SEQRES 13 B 353 TYR LEU GLN SER THR HIS ALA PRO THR HIS SER ASP TYR SEQRES 14 B 353 THR MET THR LEU LEU ASP LEU PHE GLU VAL GLU LYS ASP SEQRES 15 B 353 GLY GLU LYS GLU ALA PHE ARG GLU ASP LEU HIS ASN ARG SEQRES 16 B 353 MET LEU LEU TRP HIS GLY SER ARG MET SER ASN TRP VAL SEQRES 17 B 353 GLY ILE LEU SER HIS GLY LEU ARG ILE ALA PRO PRO GLU SEQRES 18 B 353 ALA PRO ILE THR GLY TYR MET PHE GLY LYS GLY ILE TYR SEQRES 19 B 353 PHE ALA ASP MET SER SER LYS SER ALA ASN TYR CYS PHE SEQRES 20 B 353 ALA SER ARG LEU LYS ASN THR GLY LEU LEU LEU LEU SER SEQRES 21 B 353 GLU VAL ALA LEU GLY GLN CYS ASN GLU LEU LEU GLU ALA SEQRES 22 B 353 ASN PRO LYS ALA GLU GLY LEU LEU GLN GLY LYS HIS SER SEQRES 23 B 353 THR LYS GLY LEU GLY LYS MET ALA PRO SER SER ALA HIS SEQRES 24 B 353 PHE VAL THR LEU ASN GLY SER THR VAL PRO LEU GLY PRO SEQRES 25 B 353 ALA SER ASP THR GLY ILE LEU ASN PRO ASP GLY TYR THR SEQRES 26 B 353 LEU ASN TYR ASN GLU TYR ILE VAL TYR ASN PRO ASN GLN SEQRES 27 B 353 VAL ARG MET ARG TYR LEU LEU LYS VAL GLN PHE ASN PHE SEQRES 28 B 353 LEU GLN SEQRES 1 A 353 GLY PRO GLU SER GLN LEU ASP LEU ARG VAL GLN GLU LEU SEQRES 2 A 353 ILE LYS LEU ILE CYS ASN VAL GLN ALA MET GLU GLU MET SEQRES 3 A 353 MET MET GLU MET LYS TYR ASN THR LYS LYS ALA PRO LEU SEQRES 4 A 353 GLY LYS LEU THR VAL ALA GLN ILE LYS ALA GLY TYR GLN SEQRES 5 A 353 SER LEU LYS LYS ILE GLU ASP CYS ILE ARG ALA GLY GLN SEQRES 6 A 353 HIS GLY ARG ALA LEU MET GLU ALA CYS ASN GLU PHE TYR SEQRES 7 A 353 THR ARG ILE PRO HIS ASP PHE GLY LEU ARG THR PRO PRO SEQRES 8 A 353 LEU ILE ARG THR GLN LYS GLU LEU SER GLU LYS ILE GLN SEQRES 9 A 353 LEU LEU GLU ALA LEU GLY ASP ILE GLU ILE ALA ILE LYS SEQRES 10 A 353 LEU VAL LYS SER GLU ARG GLN GLY LEU GLU HIS PRO LEU SEQRES 11 A 353 ASP GLN HIS TYR ARG ASN LEU HIS CYS ALA LEU ARG PRO SEQRES 12 A 353 LEU ASP HIS GLU SER TYR GLU PHE LYS VAL ILE SER GLN SEQRES 13 A 353 TYR LEU GLN SER THR HIS ALA PRO THR HIS SER ASP TYR SEQRES 14 A 353 THR MET THR LEU LEU ASP LEU PHE GLU VAL GLU LYS ASP SEQRES 15 A 353 GLY GLU LYS GLU ALA PHE ARG GLU ASP LEU HIS ASN ARG SEQRES 16 A 353 MET LEU LEU TRP HIS GLY SER ARG MET SER ASN TRP VAL SEQRES 17 A 353 GLY ILE LEU SER HIS GLY LEU ARG ILE ALA PRO PRO GLU SEQRES 18 A 353 ALA PRO ILE THR GLY TYR MET PHE GLY LYS GLY ILE TYR SEQRES 19 A 353 PHE ALA ASP MET SER SER LYS SER ALA ASN TYR CYS PHE SEQRES 20 A 353 ALA SER ARG LEU LYS ASN THR GLY LEU LEU LEU LEU SER SEQRES 21 A 353 GLU VAL ALA LEU GLY GLN CYS ASN GLU LEU LEU GLU ALA SEQRES 22 A 353 ASN PRO LYS ALA GLU GLY LEU LEU GLN GLY LYS HIS SER SEQRES 23 A 353 THR LYS GLY LEU GLY LYS MET ALA PRO SER SER ALA HIS SEQRES 24 A 353 PHE VAL THR LEU ASN GLY SER THR VAL PRO LEU GLY PRO SEQRES 25 A 353 ALA SER ASP THR GLY ILE LEU ASN PRO ASP GLY TYR THR SEQRES 26 A 353 LEU ASN TYR ASN GLU TYR ILE VAL TYR ASN PRO ASN GLN SEQRES 27 A 353 VAL ARG MET ARG TYR LEU LEU LYS VAL GLN PHE ASN PHE SEQRES 28 A 353 LEU GLN HET GOL B 601 6 HET 25I B 602 34 HET GOL A 601 6 HET 25I A 602 34 HETNAM GOL GLYCEROL HETNAM 25I FLUZOPARIB HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN 25I SHR3162 FORMUL 3 GOL 2(C3 H8 O3) FORMUL 4 25I 2(C22 H16 F4 N6 O2) FORMUL 7 HOH *229(H2 O) HELIX 1 AA1 ASP B 235 CYS B 246 1 12 HELIX 2 AA2 ASN B 247 GLU B 257 1 11 HELIX 3 AA3 PRO B 266 LEU B 270 5 5 HELIX 4 AA4 THR B 271 GLY B 292 1 22 HELIX 5 AA5 GLY B 295 ILE B 309 1 15 HELIX 6 AA6 THR B 323 SER B 349 1 27 HELIX 7 AA7 HIS B 356 ASN B 364 1 9 HELIX 8 AA8 SER B 376 THR B 389 1 14 HELIX 9 AA9 GLY B 411 PHE B 416 1 6 HELIX 10 AB1 ASN B 434 GLY B 442 1 9 HELIX 11 AB2 PRO B 451 TYR B 455 5 5 HELIX 12 AB3 MET B 466 ASN B 472 1 7 HELIX 13 AB4 TYR B 473 PHE B 475 5 3 HELIX 14 AB5 LYS B 504 LEU B 509 5 6 HELIX 15 AB6 ASN B 563 ASN B 565 5 3 HELIX 16 AB7 ASP A 235 CYS A 246 1 12 HELIX 17 AB8 ASN A 247 MET A 258 1 12 HELIX 18 AB9 PRO A 266 LEU A 270 5 5 HELIX 19 AC1 THR A 271 ALA A 291 1 21 HELIX 20 AC2 GLY A 295 ILE A 309 1 15 HELIX 21 AC3 THR A 323 SER A 349 1 27 HELIX 22 AC4 HIS A 356 HIS A 366 1 11 HELIX 23 AC5 SER A 376 THR A 389 1 14 HELIX 24 AC6 GLY A 411 PHE A 416 1 6 HELIX 25 AC7 ARG A 431 SER A 433 5 3 HELIX 26 AC8 ASN A 434 GLY A 442 1 9 HELIX 27 AC9 PRO A 451 TYR A 455 5 5 HELIX 28 AD1 MET A 466 ASN A 472 1 7 HELIX 29 AD2 TYR A 473 PHE A 475 5 3 HELIX 30 AD3 LYS A 504 LEU A 509 5 6 HELIX 31 AD4 SER A 525 PHE A 528 5 4 HELIX 32 AD5 ASN A 563 ASN A 565 5 3 SHEET 1 AA1 5 CYS B 367 PRO B 371 0 SHEET 2 AA1 5 TYR B 397 LYS B 409 -1 O GLU B 406 N ARG B 370 SHEET 3 AA1 5 VAL B 567 PHE B 579 -1 O ARG B 570 N VAL B 407 SHEET 4 AA1 5 THR B 482 ALA B 491 -1 N GLU B 489 O ARG B 568 SHEET 5 AA1 5 ARG B 423 GLY B 429 -1 N HIS B 428 O LEU B 486 SHEET 1 AA2 4 ILE B 461 PHE B 463 0 SHEET 2 AA2 4 GLU B 558 VAL B 561 -1 O TYR B 559 N PHE B 463 SHEET 3 AA2 4 SER B 514 GLY B 517 -1 N GLY B 517 O GLU B 558 SHEET 4 AA2 4 CYS B 495 LEU B 498 1 N LEU B 498 O LYS B 516 SHEET 1 AA3 2 MET B 521 PRO B 523 0 SHEET 2 AA3 2 ALA B 541 ASP B 543 -1 O SER B 542 N ALA B 522 SHEET 1 AA4 2 VAL B 529 LEU B 531 0 SHEET 2 AA4 2 SER B 534 VAL B 536 -1 O SER B 534 N LEU B 531 SHEET 1 AA5 5 CYS A 367 PRO A 371 0 SHEET 2 AA5 5 TYR A 397 LYS A 409 -1 O GLU A 408 N ALA A 368 SHEET 3 AA5 5 VAL A 567 PHE A 579 -1 O GLN A 576 N THR A 400 SHEET 4 AA5 5 THR A 482 ALA A 491 -1 N GLY A 483 O VAL A 575 SHEET 5 AA5 5 ARG A 423 GLY A 429 -1 N HIS A 428 O LEU A 486 SHEET 1 AA6 4 ILE A 461 PHE A 463 0 SHEET 2 AA6 4 GLU A 558 VAL A 561 -1 O VAL A 561 N ILE A 461 SHEET 3 AA6 4 SER A 514 GLY A 517 -1 N THR A 515 O ILE A 560 SHEET 4 AA6 4 CYS A 495 LEU A 498 1 N ASN A 496 O LYS A 516 SHEET 1 AA7 2 MET A 521 PRO A 523 0 SHEET 2 AA7 2 ALA A 541 ASP A 543 -1 O SER A 542 N ALA A 522 SHEET 1 AA8 2 VAL A 529 LEU A 531 0 SHEET 2 AA8 2 SER A 534 VAL A 536 -1 O SER A 534 N LEU A 531 CISPEP 1 GLY B 539 PRO B 540 0 25.70 CISPEP 2 GLY A 539 PRO A 540 0 4.28 CRYST1 41.010 85.584 95.413 90.00 90.03 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024384 0.000000 0.000013 0.00000 SCALE2 0.000000 0.011684 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010481 0.00000